Cargando…
Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis
We experienced a case of the successful treatment of intractable pulmonary aspergillosis with inhaled liposomal amphotericin B (L-AMB) and oral voriconazole (VRCZ). A 52-year-old man was admitted to our hospital with a fever. Chest computed tomography (CT) revealed an infiltrative shadow. Two separa...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381164/ https://www.ncbi.nlm.nih.gov/pubmed/33678738 http://dx.doi.org/10.2169/internalmedicine.6305-20 |
_version_ | 1783741314182938624 |
---|---|
author | Hamada, Noboru Ishiga, Mitsunori Tanaka, Suzuka Ooue, Yasuhiro Itano, Junko Tanaka, Hisaaki Yuzurio, Shota Horiuchi, Takeshi Suwaki, Toshimitsu Kimura, Goro Tanimoto, Yasushi |
author_facet | Hamada, Noboru Ishiga, Mitsunori Tanaka, Suzuka Ooue, Yasuhiro Itano, Junko Tanaka, Hisaaki Yuzurio, Shota Horiuchi, Takeshi Suwaki, Toshimitsu Kimura, Goro Tanimoto, Yasushi |
author_sort | Hamada, Noboru |
collection | PubMed |
description | We experienced a case of the successful treatment of intractable pulmonary aspergillosis with inhaled liposomal amphotericin B (L-AMB) and oral voriconazole (VRCZ). A 52-year-old man was admitted to our hospital with a fever. Chest computed tomography (CT) revealed an infiltrative shadow. Two separate sputum cultures detected Aspergillus niger. Although we treated the patient with single and combined antifungal agents, the infiltrative shadow worsened. After obtaining sufficient informed consent from the patient, we switched him to an inhaled L-AMB. The infiltrative shadow subsequently improved. The patient has remained well for one year without exacerbation. We herein report the usefulness of inhaled L-AMB and oral VRCZ. |
format | Online Article Text |
id | pubmed-8381164 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-83811642021-08-30 Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis Hamada, Noboru Ishiga, Mitsunori Tanaka, Suzuka Ooue, Yasuhiro Itano, Junko Tanaka, Hisaaki Yuzurio, Shota Horiuchi, Takeshi Suwaki, Toshimitsu Kimura, Goro Tanimoto, Yasushi Intern Med Case Report We experienced a case of the successful treatment of intractable pulmonary aspergillosis with inhaled liposomal amphotericin B (L-AMB) and oral voriconazole (VRCZ). A 52-year-old man was admitted to our hospital with a fever. Chest computed tomography (CT) revealed an infiltrative shadow. Two separate sputum cultures detected Aspergillus niger. Although we treated the patient with single and combined antifungal agents, the infiltrative shadow worsened. After obtaining sufficient informed consent from the patient, we switched him to an inhaled L-AMB. The infiltrative shadow subsequently improved. The patient has remained well for one year without exacerbation. We herein report the usefulness of inhaled L-AMB and oral VRCZ. The Japanese Society of Internal Medicine 2021-03-08 2021-08-01 /pmc/articles/PMC8381164/ /pubmed/33678738 http://dx.doi.org/10.2169/internalmedicine.6305-20 Text en Copyright © 2021 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Hamada, Noboru Ishiga, Mitsunori Tanaka, Suzuka Ooue, Yasuhiro Itano, Junko Tanaka, Hisaaki Yuzurio, Shota Horiuchi, Takeshi Suwaki, Toshimitsu Kimura, Goro Tanimoto, Yasushi Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis |
title | Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis |
title_full | Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis |
title_fullStr | Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis |
title_full_unstemmed | Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis |
title_short | Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis |
title_sort | successful treatment of antifungal combination therapy with inhaled liposomal amphotericin b and oral voriconazole for intractable chronic progressive pulmonary aspergillosis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381164/ https://www.ncbi.nlm.nih.gov/pubmed/33678738 http://dx.doi.org/10.2169/internalmedicine.6305-20 |
work_keys_str_mv | AT hamadanoboru successfultreatmentofantifungalcombinationtherapywithinhaledliposomalamphotericinbandoralvoriconazoleforintractablechronicprogressivepulmonaryaspergillosis AT ishigamitsunori successfultreatmentofantifungalcombinationtherapywithinhaledliposomalamphotericinbandoralvoriconazoleforintractablechronicprogressivepulmonaryaspergillosis AT tanakasuzuka successfultreatmentofantifungalcombinationtherapywithinhaledliposomalamphotericinbandoralvoriconazoleforintractablechronicprogressivepulmonaryaspergillosis AT ooueyasuhiro successfultreatmentofantifungalcombinationtherapywithinhaledliposomalamphotericinbandoralvoriconazoleforintractablechronicprogressivepulmonaryaspergillosis AT itanojunko successfultreatmentofantifungalcombinationtherapywithinhaledliposomalamphotericinbandoralvoriconazoleforintractablechronicprogressivepulmonaryaspergillosis AT tanakahisaaki successfultreatmentofantifungalcombinationtherapywithinhaledliposomalamphotericinbandoralvoriconazoleforintractablechronicprogressivepulmonaryaspergillosis AT yuzurioshota successfultreatmentofantifungalcombinationtherapywithinhaledliposomalamphotericinbandoralvoriconazoleforintractablechronicprogressivepulmonaryaspergillosis AT horiuchitakeshi successfultreatmentofantifungalcombinationtherapywithinhaledliposomalamphotericinbandoralvoriconazoleforintractablechronicprogressivepulmonaryaspergillosis AT suwakitoshimitsu successfultreatmentofantifungalcombinationtherapywithinhaledliposomalamphotericinbandoralvoriconazoleforintractablechronicprogressivepulmonaryaspergillosis AT kimuragoro successfultreatmentofantifungalcombinationtherapywithinhaledliposomalamphotericinbandoralvoriconazoleforintractablechronicprogressivepulmonaryaspergillosis AT tanimotoyasushi successfultreatmentofantifungalcombinationtherapywithinhaledliposomalamphotericinbandoralvoriconazoleforintractablechronicprogressivepulmonaryaspergillosis |